Advanced or Inoperable Malignant Melanoma With BRAF Mutation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced or Inoperable Malignant Melanoma With BRAF Mutation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

SuspendedPhase 1

NCT01841463

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignan…

* An Open Label, Multicenter, Phase I Extension Study of an Oral Cdk Inhibitor P1446A-05 Administered with an Oral BRAF Inhibitor Vemurafenib (Zelboraf®) in Pat…

United States100 participantsStarted 2013-08

Treatment: P1446A-05, Vemurafenib (Zelboraf®)